• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Hampshire Hospitals NHS Foundation Trust

    EST. 2012
    619论文总数
    1.2万引用总数

    Hampshire Hospitals NHS Foundation Trust is an NHS foundation trust providing services in Hampshire and parts of west Berkshire. It was established in January 2012 as the result of the integration of Basingstoke and North Hampshire NHS Foundation Trust and Winchester and Eastleigh Healthcare Trust. It runs Andover War Memorial Hospital, Basingstoke and North Hampshire Hospital and Royal Hampshire County Hospital. (RHCH) The Trust also runs a private hospital on the same site as BNHH - the Candover Clinic.

    论文量&引用量时间轴

    机构学者

    排序
    Richard G Hindley
    Richard G Hindley
    Hampshire Hospitals NHS Foundation Trust
    论文:40引用:0H-index:0
    John Ramage
    John Ramage
    Institute of Liver Studies, King’s College Hospital NHS Foundation Trust;Faculty of Health and Wellbeing, University of Winchester
    论文:35引用:0H-index:0
    Kordo Saeed
    Kordo Saeed
    Hampshire Hospitals NHS Foundation Trust, Royal Hampshire County Hospital
    论文:27引用:0H-index:0
    Hashim Ahmed
    Hashim Ahmed
    Department of Surgery and Cancer, Faculty of Medicine, Imperial College London
    论文:19引用:0H-index:0
    Myrddin Rees
    Myrddin Rees
    Hampshire Hospitals NHS Foundation Trust
    论文:14引用:0H-index:0
    Matthew Dryden
    Matthew Dryden
    Hampshire Hospitals NHS Foundation Trust
    论文:14引用:0H-index:0
    Chandrakumaran Kandiah
    Chandrakumaran Kandiah
    Basingstoke & N Hampshire NHS Fdn Trust
    论文:14引用:0H-index:0
    Savita Rangarajan
    Savita Rangarajan
    University of Southampton
    论文:13引用:0H-index:0
    Mark Emberton
    Mark Emberton
    Faculty of Medical Sciences, University College London;Division of Surgery and Interventional Science, Royal Free and University College London School of Medicine, University College London;University College London Hospitals
    论文:13引用:0H-index:0

    论文(620)

    年份
    起
    –
    止
    排序
    1AI Decision Support for Increasing Prostate Biopsy Efficiency: a Retrospective Multicentre, Multiscanner Study
    Nikita Sushentsev, Zobair Arya, Jobie Budd, Amy Frary, Nadia Moreira da Silva, Mirjana Ferrer Rodriguez,Paul Burn, Richard Hindley,Nikhil Vasdev, Mohamed Ibrahim, Alison Bradley, Adrian Andreou,

    To develop and retrospectively validate an artificial intelligence-based decision support system (AI-DSS) for optimising prostate biopsy decisions and improving benefit-to-harm ratios. This retrospective, multicentre, multiscanner study used data from 1022 patients. An AI-DSS integrating PI-RADS scores, automated prostate-specific antigen density (PSAd), and deep-learning imaging risk scores was developed on 770 cases and validated on an independent cohort of 252 men from six UK centres. The AI-DSS performance was benchmarked against the real-world clinical decisions (reference standard) using grade selectivity, biopsy efficiency, and selective biopsy avoidance as outcome measures. Biopsy-proven detection of grade group (GG) ≥ 2 disease was the reference standard. In the validation cohort of 252 patients (mean age, 67.3 years), 137 underwent biopsy and 79 (31

    2026European Radiology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: an Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries
    Alexander Light,Max Peters, Archana Gopalakrishnan,Nikhil Mayor, Emma Cullen, Ranil Johann Boaz,Joseph M Norris, Samuel Morris,Manit Arya,Mariana Bertoncelli Tanaka,Alan Doherty,Tim Dudderidge,

    BACKGROUND AND OBJECTIVE:Long-term outcome data for focal therapy using high-intensity focused ultrasound (HIFU) or cryotherapy for nonmetastatic prostate cancer are needed. We report 10-yr cancer control outcomes. METHODS:Patients with nonmetastatic prostate cancer who underwent primary focal HIFU or cryotherapy and had at least 6 mo follow-up were identified from the UK HIFU Evaluation and Assessment of Treatment (HEAT) and International Cryotherapy Evaluation (ICE) prospectively maintained registries. The intervention included up to two focal ablative sessions. The primary outcome was cancer-specific mortality. Secondary outcomes were all-cause mortality, metastasis, local retreatment, radical treatment, and androgen-deprivation therapy (ADT) use. KEY FINDINGS AND LIMITATIONS:A total of 3477 patients (HIFU: n = 2897; cryotherapy: n = 580) were included from 14 UK centres (2004-2024). A total of 48%, 23%, and 25% had European Association of Urology (EAU) 2025-version favourable intermediate-, unfavourable-intermediate-, and high-risk disease, respectively. Ten-yr cancer-specific mortality was 0.13% (95% confidence interval [CI] = 0.027-0.45%). Ten-yr all-cause mortality and metastases were 12% (95% CI = 8.8-15%) and 3.3% (95% CI = 2.1-4.9%), respectively. Ten-yr ADT use was 14% (95% CI = 11-17%). Ten-yr local retreatment and radical treatment were 33% (95% CI = 30-37%) and 30% (95% CI = 27-34%), respectively, on an intention-to-treat basis. In a post hoc per-protocol analysis, undertaken to estimate outcomes under stricter adherence to the two focal ablative session protocol, patients who underwent radical treatment despite being potentially eligible for a further focal ablative session were censored at the time of radical treatment; 10-yr local retreatment and radical treatment were 13% (95% CI = 11-16%) and 8.9% (95% CI = 6.9-11%), respectively. The observational study design is the main limitation. CONCLUSIONS AND CLINICAL IMPLICATIONS:Focal therapy using up to two sessions of focal HIFU or cryotherapy could be considered as a first-line treatment for well-selected patients of nonmetastatic prostate cancer alongside radical treatment. Future research priorities should include the development of a dedicated prognostic risk calculator, further prospective assessment of focal therapy for high-risk disease, and improvements in the detection and management of locally recurrent disease.

    2026European urology(2026)
    引用
    AI阅读
    加入学术空间
    3British Society of Gastroenterology Consultant Gastroenterologist Job Planning Guidance
    Elizabeth Bird-Lieberman, Monica Bose,Matthew Kurien, Matthew Warren, Harriet Gordon

    Job planning is a mandatory part of the national terms and conditions for National Health Service (NHS) consultants. Gastroenterology and hepatology services are experiencing increasing demand, workforce pressures and evolving models of care. This document aims to provide detailed guidance for consultant gastroenterologist job planning aligned with national standards and current NHS service requirements. Guidance was developed by the British Society of Gastroenterology Job Planning Advisory Group, informed by national policy, Royal College of Physicians recommendations and expert consensus. Key areas addressed include direct clinical care, supporting professional activities, outpatient services, endoscopy, inpatient care, emergency and on-call commitments and single point of access services. Recommendations are provided to support equitable and sustainable job planning. In conclusion effective job planning is essential to deliver safe, high-quality patient care while supporting workforce sustainability. A structured, transparent and collaborative approach is required.

    2026FRONTLINE GASTROENTEROLOGY(2026)
    引用
    AI阅读
    加入学术空间
    4The Evidence Landscape for Direct-from-urine Antibiotic Susceptibility Testing (AST) for Urinary Tract Infection (UTI): a Scoping Review
    Atiyeh Asadpour, Richa Sharma, Jana Suklan,Stephen P Kidd, Julie Hart, Alexander Daniel Edwards, Sarah Helen Needs

    Background:Antimicrobial susceptibility tests (AST) are vital to guide antibiotic selection to treat bacterial infections, including urinary tract infections (UTI). Current laboratory AST takes at least 2 days. Direct testing of urine samples could speed up testing, with rapid reporting aiding timely treatment. Method:A scoping review was conducted to identify studies assessing the accuracy of direct-from-urine AST, and map the breadth of evidence. Studies that measured overall categorical agreement (CA) compared to a reference method were selected, and the reported accuracy, the type of AST method and study methodology assessed. Results:In total, 33 studies were identified that met the inclusion criteria (1976-2024). These reported overall CA for direct-from-urine AST ranging from 78.7% to 100% compared to a reference method. These studies varied in the AST method used; in urine sample collection, origin and processing; in the antibiotics evaluated; in study design and data analysis. The most common AST method evaluated was direct-from-urine disc diffusion. Most studies reported accuracy only for samples containing a single Gram-negative organism. Conclusion:Although increasing numbers of studies report the accuracy of direct-from-urine AST, heterogeneity prevented systematic comparison of methods or detailed meta-analysis. Many studies reported overall accuracy >90% CA for urine samples containing a single Gram-negative organism across several direct-from-urine AST methods, offering potential time saving compared with current methods. However, as single organism samples represent only a subset of urines taken from UTI patients, additional studies-that include analysis of samples containing mixed cultures and Gram-positive isolates-are still required.

    2026JAC-antimicrobial resistance(2026)
    引用
    AI阅读
    加入学术空间
    5The Need For, Feasibility Of, and Barriers to Implementation of a Trauma Traveling Fellowship: a Survey of ESTES Members
    Jared M. Wohlgemut,Shailvi Gupta, Stefano P. B. Cioffi, Heura Llaquet-Bayo, Helen S. Wohlgemut, Jonathan Hobby,Shahin Mohseni,Diego Mariani,Christine Gaarder,Gary A. Bass, Susan Brundage

    Many European surgeons lack access to high-volume trauma training. A Trauma Traveling Fellowship, supported by the European Society of Trauma and Emergency Surgery (ESTES), could broaden educational and clinical exposure to trauma care, but feasibility and implementation factors are unclear. The aims of this survey are to assess the aspirations, expectations, and perceived challenges of prospective fellows and host centres for an ESTES Trauma Traveling Fellowship. A cross-sectional, web-based survey was distributed to all ESTES members, capturing demographics, fellowship aspirations, perceived barriers, and host centre capacities. The survey incorporated Likert scales, free-text responses, and was guided by the Consolidated Framework for Implementation Research (CFIR) and the Reach, Effectiveness, Adoption, Implementation, and Maintenance / Practical Robust Implementation and Sustainability Model (RE-AIM/PRISM). Of 903 invited, 210 responses (23.3

    2026European Journal of Trauma and Emergency Surgery(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 620 篇论文

    合作机构(100)

    南安普顿大学医院 NHS 基金会信托合作论文 43
    帝国理工学院合作论文 38
    南安普顿大学合作论文 32
    卢旺天主教大学合作论文 26
    牛津大学合作论文 25
    Royal Free London NHS Foundation Trust合作论文 25
    盖伊和圣托马斯 NHS 基金会信托合作论文 21
    North Bristol NHS Trust合作论文 20
    Southend University Hospital NHS Foundation Trust合作论文 20
    伦敦大学学院合作论文 20

    机构统计